Ceretype Neuromedicine, Inc.

Biotechnology company · Cambridge, Massachusetts, United States

Ceretype Neuromedicine, Inc. is a biotechnology company headquartered in Cambridge, Massachusetts, United States. Its earliest recorded incorporation is in 2018. It has reported private securities offerings to the US SEC, most recently $400,000 sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Ceretype Neuromedicine at a glance

Typebiotechnology company

HeadquartersCambridge, Massachusetts, United States

Earliest incorporation on record2018

SEC CIK1884863

What does Ceretype Neuromedicine do?

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $400,000 sold (2025).

Frequently asked questions about Ceretype Neuromedicine

Where is Ceretype Neuromedicine headquartered?

Ceretype Neuromedicine, Inc. is headquartered in Cambridge, Massachusetts, United States.

What does Ceretype Neuromedicine do?

Ceretype Neuromedicine, Inc. is a biotechnology company.

When was Ceretype Neuromedicine founded?

The earliest incorporation on record for Ceretype Neuromedicine, Inc. is in 2018, according to public company registers.

Similar companies

Editas Medicine, Inc.Cambridge, Massachusetts, United States
Moderna, Inc.Cambridge, Massachusetts, United States
Relay Therapeutics, Inc.Cambridge, Massachusetts, United States
Beam Therapeutics Inc.Cambridge, Massachusetts, United States
Genzyme CorpCambridge, Massachusetts, United States
Neutrolis Inc.Cambridge, Massachusetts, United States
Biogen Inc.Cambridge, Massachusetts, United States
Black Diamond Therapeutics, Inc.Cambridge, Massachusetts, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences